The Drug Hunter’s Assistant: Accelerating Drug Discovery With AI
Are The High Expectations Justified?
The hype around Artificial Intelligence has been deafening in recent years, but real progress can only come when drug discovery culture and regulators catch up with the technology.
You may also be interested in...
The tireless pace of change in hemato-oncology was showcased in Orlando.
Janssen’s hemato-oncology success rolls on with impressive new overall survival data
While the BCMA-targeting CAR-T competition is grabbing attention, bluebird has good news in sickle cell therapy.